Back to Authors

Charpentier, Ann-Marie

A5077317829 | I4210142730

Mayo Clinic

Centre Hospitalier de l’Université de Montréal

Citations 1

T087: Brentuximab vedotin (Bv) Demonstrates Superior Event-Free Survival in Pediatric High-Risk Hodgkin Lymphoma

HemaSphere | October 10, 2022 | Volume: 6 | Issue: No issue available | Pages: 40-40

10.1097/01.hs9.0000890916.12776.84